Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-15 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +31,000 31,000
2025-06-12 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2024-06-07 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2023-06-07 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-06-08 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2021-06-09 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-09 SARGEN GREGORY Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2020-01-10 SARGEN GREGORY Director Grant or award +31,000 31,000

Page 1 of 1 · 8 trades